Clinical Trials Logo

Clinical Trial Summary

Objective: To analyze the survival of patients with a reduction in the number of resected LN in patients submitted to neoadjuvant and total excision of the mesorectum with rectal cancer.

Expected results:

Survival rate between patients Complete Pathologic Response with less than 12 LN and 12 or more LN.

To determine the difference in survival between patients with less than 12 LN in complete versus incomplete response.


Clinical Trial Description

According to the International Union Against Cancer a minimum of 12 lymph nodes (LN) should be obtained in the surgical specimen for colorectal cancer staging. Recent studies have reported that the use of neoadjuvant chemoradiotherapy (QRN) may result in failure to obtain the minimum number of LN in the piece in 30-52% of patients. Objective: To analyze the survival of patients with a reduction in the number of resected LN in patients submitted to neoadjuvant and total excision of the mesorectum with rectal cancer. Patients and methods: From January 2013 to January 2015, patients with rectal cancer were submitted to QRN (5-FU and 5040 Gys) followed by total excision of mesorectum with ligation of the inferior mesenteric vessels in their roots. Patients with T3, T4 and / or N + staging that were up to 10 cm from the anal border were included. Patients whose treatment with neoadjuvant chemoradiotherapy was incomplete or who had significant delays in re- staging and / or performing the surgery were excluded. All were staged by rectal examination, colonoscopy, chest and abdominal CT, and pelvic MRI, and also re-staged 8 weeks after neoadjuvant termination, operated and submitted to total excision of the mesorectum. The patients were divided into 4 groups: a) Incomplete pathological response with less than 12 LN. b) Incomplete pathological response with 12 or more LN. c) Complete pathological response with less than 12 LN. d) Complete pathological response with 12 or more LN. The possible variables related to the number of LN obtained and related to general and disease free survival were studied.

Expected results:

To analyze the survival rate between patients Complete Pathologic Response with less than 12 LN and 12 or more LN. To determine the difference in survival between patients with less than 12 LN in complete versus incomplete response. Demonstrate that patients with complete pathologic response and less than 12 LN have a disease-free survival equal to or better than patients with 12 LN or more. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04456283
Study type Observational [Patient Registry]
Source University of Sao Paulo
Contact
Status Recruiting
Phase
Start date May 20, 2019
Completion date July 15, 2021

See also
  Status Clinical Trial Phase
Completed NCT04160650 - Educational Nursing Intervention Among Patients With Colorectal Cancer During Chemotherapy N/A
Recruiting NCT02948348 - Study to Nivolumab Following Preoperative Chemoradiotherapy Phase 1/Phase 2
Recruiting NCT01403883 - Psychological and Enterostomal Therapy Care N/A
Recruiting NCT05179824 - Tempus Priority Study: A Pan-tumor Observational Study
Completed NCT04716010 - Developing and Evaluating Product Messaging N/A
Completed NCT04319354 - Evaluation of cfDNA as a Marker of Response in Rectal Cancer N/A
Completed NCT02641691 - Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum Phase 2
Recruiting NCT03573791 - Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
Recruiting NCT05358704 - Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer Phase 2
Not yet recruiting NCT03910283 - Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer N/A
Recruiting NCT03896958 - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Recruiting NCT05887531 - Abdominopelvic Cancer Prehabilitation N/A
Completed NCT04880772 - Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery N/A
Completed NCT00271986 - Peritoneal Microdialysis in Patients Undergoing Low Anterior Resection (LAR) for Recto-sigmoid Cancer N/A
Recruiting NCT04095299 - Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients Phase 2
Active, not recruiting NCT06181201 - Association Between the Composition of the Intestinal Microbiota and Tumor Response in Locally Advanced Rectal Cancer
Not yet recruiting NCT03607643 - A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies Phase 1/Phase 2
Terminated NCT04812743 - Colorectal Health Research Champions N/A
Recruiting NCT03452774 - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting NCT05732389 - Immunotherapy in Patients With Early dMMR Rectal Cancer Phase 2